United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - nivolumab - solution for infusion - 10mg/1ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bristol-myers squibb, united states - nivolumab - solution for injection - 10 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bristol-myers squibb, united states - nivolumab - solution for injection - 10 mg/ml

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - nivolumab; relatlimab - infusion, solution concentrate - nivolumab 240mg per vial; relatlimab 80mg per vial

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

ono pharmaceutical co., ltd. - nivolumab (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bristol-myers squibb - nivolumab (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bristol-myers squibb - nivolumab (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

ono pharmaceutical co., ltd. - nivolumab (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

bristol-myers squibb - nivolumab (genetical recombination) - injection

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

ono pharmaceutical co., ltd. - nivolumab (genetical recombination) - injection